← All organizations
Instituto Mexicano del Seguro Social
GovernmentWebsite ↗
Also known as: Alejandro Gonzalez-Ojeda | Gabriel Fernández Yáñez | Germán Ramón Bautista López | Hospital de Especialidades, Centro Medico Nacional "La Raza", Instituto Mexicano del Seguro Social | Instituto Mexica del Seguro Social | Instituto Mexicano del Seguro Social | Instituto Mexicano del Seguro Social, Unidad de Investigación Biomédica 02 | Luis Jonathan González | Rodolfo Guardado Mendoza
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Dec 30, 2025
Timeline
1940s
- Jan 1, 1943
Instituto Mexicano del Seguro Social— Founded
Drugs by trial phase (112 distinct, 97 trials)
Phase 4 (37 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Ankle Fractures
- Carcinoma in Situ
- Cognitive Dysfunction
- Coronary Artery Disease
- Cystic Fibrosis
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Enterocolitis
- Enterocolitis, Necrotizing
- Fatigue
- Fibrosis
- Fractures, Bone
- Heart Diseases
- Hemorrhoids
- HIV Infections
- Hypertension
- Hypertension, Pulmonary
- Immunologic Deficiency Syndromes
- Infarction
- Inflammation
- Influenza, Human
- Insulin Resistance
- Kidney Failure, Chronic
- Labor Pain
- Leukemia
- Leukemia, Lymphoid
- Lymphocele
- Malnutrition
- Mandibular Fractures
- Melanosis
- Metabolic Diseases
- Metabolic Syndrome
- Multiple Sclerosis
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Myocardial Ischemia
- Nausea
- Neoplasms
- Pancreatitis
- Parkinson Disease
- Postoperative Complications
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Renal Insufficiency
- Respiration Disorders
- Retinal Diseases
- Retinopathy of Prematurity
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sclerosis
- Sepsis
- Spinal Cord Injuries
- Toxemia
- Vomiting
- Wounds and Injuries
Recent trials (50)
- NCT07297589Lead sponsorPhase 3Dec 30, 2025
- NCT07297589Sponsor investigatorPhase 3Dec 30, 2025
- NCT07295223Lead sponsorPhase 3Dec 15, 2025
- NCT07295223Sponsor investigatorPhase 3Dec 15, 2025
- NCT07073846OfficialPhase 4Oct 6, 2025
- NCT07073846Lead sponsorPhase 4Oct 6, 2025
- NCT07073846Sponsor investigatorPhase 4Oct 6, 2025
- NCT07075146OfficialPhase 3May 5, 2025
- NCT07075146Lead sponsorPhase 3May 5, 2025
- NCT07075146Sponsor investigatorPhase 3May 5, 2025
- NCT07075146CollaboratorPhase 3May 5, 2025
- NCT06787976Sponsor investigatorPhase 4Apr 19, 2025
- NCT06787976Lead sponsorPhase 4Apr 19, 2025
- NCT07031063OfficialPhase 4Apr 1, 2025
- NCT07031063Lead sponsorPhase 4Apr 1, 2025
Details
- Founded
- Mexico City, MX Jan 1, 1943
- Last known activity
- Dec 30, 2025